Search

everythinglearnresearchcommunity

for

Search:↓

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Fetal ovaries produce different hormones than adult ovaries, and endocrine-disrupting chemicals may affect this process.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

The document recommends a multidisciplinary approach and experience sharing to advance facial feminization surgery as a medical field.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Understanding hair biology is key to developing better treatments for hair and scalp issues.

Secondary aesthetic surgeries for gender reassignment are generally satisfying and advance overall aesthetic surgery techniques, but psychological support is important.

Omega-6 fats in certain cells boost male hormone production.

Low testosterone might be a common cause of hair loss in male dogs.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

A young girl's hyperandrogenism was caused by an adrenocortical adenoma, diagnosed and treated through detailed evaluations.

Transgender women have similar fitness to cisgender women, while transgender men have higher fat and lower strength than cisgender men; hormone therapy affects body composition and strength.

Australia needs better dermatological guidelines for gender-diverse patients.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

The document concludes that individualized Facial Feminization Surgery plans and comprehensive care are crucial for successful outcomes.

Antiandrogen therapy helps treat genetic hair loss.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

The document does not determine if adults with aphallia are fertile.